Tylosin, a macrolide antibiotic, is the first-choice drug for the prevention and treatment of mycoplasma diseases in livestock and poultry. It is mainly used for preventing and treating mycoplasma pneumonia in pigs and chickens, contagious pleuropneumonia in sheep, mycoplasma mastitis and arthritis in cattle, etc.
It is a macrolide antibiotic exclusively used for animals, extracted from the fermentation of *Streptomyces fradiae* in the genus Actinomycetes. It binds to the 50S subunit of bacterial ribosomal proteins, inhibits peptidyl transferase, affects the translocation process of ribosomal proteins, hinders peptide chain elongation, and suppresses bacterial protein synthesis, thereby achieving bacteriostatic effects.
● For the prevention and treatment of chronic respiratory diseases in poultry, infectious coryza in chickens, avian airsacculitis, infectious sinusitis, salpingitis, etc. It can also be used for mycoplasma purification in breeding poultry farms through egg injection and egg immersion.
● For the treatment of swine asthma, atrophic rhinitis, swine red diarrhea, gastroenteritis, swine erysipelas, mycoplasma arthritis, intractable diarrhea in livestock and poultry, necrotic enteritis, endometritis, etc.
● It has a good curative effect on preventing and treating secondary mycoplasma infections in livestock and poultry during outbreaks of viral diseases. It is a world-recognized first-choice drug for the treatment and prevention of mycoplasma infections in livestock and poultry.
● For the prevention and treatment of meningitis in sheep, pleuropneumonia in goats, abortion in ewes, and liver abscess in cattle.
Histamine-free, low impurity, dual fermentation method, 3E extraction technology, 11 patents